Quantcast

Neuromonics Signs Distributor Agreement With ADCO Hearing Products

June 4, 2014

Tinnitus company gives hearing instruments specialists ability to help ringing in the ears.

WESTMINSTER, Colo. (PRWEB) June 04, 2014

Neuromonics, Inc., manufacturer and distributor of clinically proven tinnitus treatment devices, has signed a distributor agreement with ADCO Hearing Products, Inc.

ADCO provides products and services to the hearing health care industry, and is an authorized distributor for products ranging from clinical and diagnostic supplies to amplified devices and hearing aid accessories. Through the agreement, the company, based in Englewood, Colo., will obtain exclusive rights to sell the Neuromonics Sanctuary device to hearing instrument specialists. The Sanctuary is a tinnitus management tool offering tinnitus sufferers on-demand relief.

ADCO will also sell the Neuromonics Haven, which hearing instrument specialists can program and individualize for patients. The Haven also is a management tool offering situational relief for tinnitus symptoms.

“Extending distribution of Neuromonics’ proven products to hearing instrument specialists is a major step for both Neuromonics and ADCO,” says Eula Adams, CEO of Neuromonics. “These specialists can directly deliver the miracle of tinnitus relief to more and more tinnitus sufferers with easy-to-use, effective technology and products from Neuromonics.”

Neuromonics manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus, the condition often described as buzzing, ringing, hissing, humming, roaring, whistling or “ringing in the ears” that someone hears in the absence of any external sound. Globally, tinnitus affects an estimated 10-15 percent of the population. In the United States alone, more than 50 million people suffer from the condition, according to the American Tinnitus Association. Usually brought on by exposure to loud noise, tinnitus is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from the condition.

Neuromonics products use calming, relaxing music embedded with a neural stimulus that interacts with the tinnitus perception, explains Adams. The music engages the auditory pathways to promote neural plastic changes. Over time, these changes help the brain to filter out the tinnitus perception, reducing tinnitus disturbance and providing long-term relief from symptoms. The compact devices are simple to use, function much like familiar consumer music players, and fit easily into patients’ lifestyles.

Neuromonics, Inc. (http://www.neuromonics.com)

Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term treatment and significant relief for those with severe tinnitus. The Haven, with the ability to program and individualize hearing profiles, is a management tool offering situational relief for tinnitus symptoms. The Sanctuary, also a management tool, works with pre-programmed profiles for on-demand relief.

With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. More than 400 licensed, trained audiologists across four continents administer the Neuromonics Tinnitus Treatment. Neuromonics news includes segments on national media including “The Doctors” and CNN.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/06/prweb11904337.htm


Source: prweb



comments powered by Disqus